The Kaplan–Meier analysis showed that low ac-DNMT1 protein levels are associated with shorter 4-year MSS (p = 0.006, log-rank test; Figure 7A) in stage IV melanoma patients. This evidence concerns the gene DNMT1 and melanoma.